Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
Diana L. Williams, Denis G. Baskin, Michael W. Schwartz
Endocrinology (2008) Vol. 150, Iss. 4, pp. 1680-1687
Open Access | Times Cited: 288

Showing 26-50 of 288 citing articles:

Liraglutide: short‐lived effect on gastric emptying—long lasting effects on body weight
Jacob Jelsing, Niels Vrang, Gitte Hansen, et al.
Diabetes Obesity and Metabolism (2012) Vol. 14, Iss. 6, pp. 531-538
Closed Access | Times Cited: 170
Glucagon-like peptide 1 and appetite
Megan J. Dailey, Timothy H. Moran
Trends in Endocrinology and Metabolism (2013) Vol. 24, Iss. 2, pp. 85-91
Open Access | Times Cited: 164
Role of the glucagon-like-peptide-1 receptor in the control of energy balance
Matthew R. Hayes, Bart C. De Jonghe, Scott E. Kanoski
Physiology & Behavior (2010) Vol. 100, Iss. 5, pp. 503-510
Open Access | Times Cited: 161
N-acylethanolamines, anandamide and food intake
Harald S. Hansen, Thi Ai Diep
Biochemical Pharmacology (2009) Vol. 78, Iss. 6, pp. 553-560
Open Access | Times Cited: 153
Molecular mechanisms underlying nutrient-stimulated incretin secretion
Helen Parker, Frank Reimann, Fiona M. Gribble
Expert Reviews in Molecular Medicine (2010) Vol. 12
Closed Access | Times Cited: 146
Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function
Jason G. Barrera, Kenneth R. Jones, James P. Herman, et al.
Journal of Neuroscience (2011) Vol. 31, Iss. 10, pp. 3904-3913
Open Access | Times Cited: 146
Hippocampal GLP-1 Receptors Influence Food Intake, Meal Size, and Effort-Based Responding for Food through Volume Transmission
Ted M. Hsu, Joel D. Hahn, Vaibhav Konanur, et al.
Neuropsychopharmacology (2014) Vol. 40, Iss. 2, pp. 327-337
Open Access | Times Cited: 145
Leptin Directly Depolarizes Preproglucagon Neurons in the Nucleus Tractus Solitarius
Kazunari Hisadome, Frank Reimann, Fiona M. Gribble, et al.
Diabetes (2010) Vol. 59, Iss. 8, pp. 1890-1898
Open Access | Times Cited: 145
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
Brian L. Furman
Toxicon (2010) Vol. 59, Iss. 4, pp. 464-471
Closed Access | Times Cited: 140
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications
Sten Madsbad
Diabetes Obesity and Metabolism (2013) Vol. 16, Iss. 1, pp. 9-21
Closed Access | Times Cited: 134
Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides
Niels Vrang, Philip J. Larsen
Progress in Neurobiology (2010) Vol. 92, Iss. 3, pp. 442-462
Closed Access | Times Cited: 130
Liraglutide and obesity: a review of the data so far
Ellen E. Ladenheim
Drug Design Development and Therapy (2015), pp. 1867-1867
Open Access | Times Cited: 125
Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor–Expressing Glutamatergic Neurons
Jessica M. Adams, Hongjuan Pei, Darleen A. Sandoval, et al.
Diabetes (2018) Vol. 67, Iss. 8, pp. 1538-1548
Open Access | Times Cited: 118
Physiology of Incretins in Health and Disease
Carolyn F. Deacon, Bo Åhrén
The Review of Diabetic Studies (2011) Vol. 8, Iss. 3, pp. 293-306
Open Access | Times Cited: 117
Central Nervous System Mechanisms Linking the Consumption of Palatable High-Fat Diets to the Defense of Greater Adiposity
Karen K. Ryan, Stephen C. Woods, Randy J. Seeley
Cell Metabolism (2012) Vol. 15, Iss. 2, pp. 137-149
Open Access | Times Cited: 110
Experience with the high-intensity sweetener saccharin impairs glucose homeostasis and GLP-1 release in rats
Susan E. Swithers, Alycia F. Laboy, Kiely Clark, et al.
Behavioural Brain Research (2012) Vol. 233, Iss. 1, pp. 1-14
Open Access | Times Cited: 109
Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent Neuron Signaling ,
Charlotte C. Ronveaux, Daniel Tomé, Helen E. Raybould
Journal of Nutrition (2015) Vol. 145, Iss. 4, pp. 672-680
Open Access | Times Cited: 106
The metabolic role of vagal afferent innervation
T.M. Zaved Waise, Helen J. Dranse, Tony K.T. Lam
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 10, pp. 625-636
Closed Access | Times Cited: 102
Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
Jennifer S. ten Kulve, Dick J. Veltman, Liselotte van Bloemendaal, et al.
Diabetologia (2015) Vol. 58, Iss. 12, pp. 2688-2698
Open Access | Times Cited: 100
A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling
Ted M. Hsu, Emily E. Noble, C M Liu, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 7, pp. 1555-1565
Open Access | Times Cited: 100
The physiological control of eating: signals, neurons, and networks
Alan G. Watts, Scott E. Kanoski, Graciela Sanchez‐Watts, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 689-813
Open Access | Times Cited: 98
Gut microbiota, nutrient sensing and energy balance
Frank A. Duca, Tony K.T. Lam
Diabetes Obesity and Metabolism (2014) Vol. 16, Iss. S1, pp. 68-76
Open Access | Times Cited: 95
Revisiting the role of protein-induced satiation and satiety
Pere Morell, Susana Fiszman
Food Hydrocolloids (2016) Vol. 68, pp. 199-210
Closed Access | Times Cited: 88
Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
Stefan Trapp, Daniel I. Brierley
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 557-570
Open Access | Times Cited: 87
A Role for GLP-1 in Treating Hyperphagia and Obesity
Harvey J. Grill
Endocrinology (2020) Vol. 161, Iss. 8
Open Access | Times Cited: 85

Scroll to top